Fighting antimicrobial resistance : who should lead the agenda?

dc.contributor.author	Sabiiti, Wilber
dc.date.accessioned	2017-12-21T12:30:20Z
dc.date.available	2017-12-21T12:30:20Z
dc.date.issued	2017-07-06
dc.identifier	250451496
dc.identifier	a8e58124-28b8-4a67-936f-48ccd0196198
dc.identifier	85033673085
dc.identifier.citation	Sabiiti , W 2017 , ' Fighting antimicrobial resistance : who should lead the agenda? ' , Journal of Infectious Diseases & Travel Medicine , vol. 1 , no. 1 , 000101 .	en
dc.identifier.other	ORCID: /0000-0002-4742-2791/work/60196332
dc.identifier.uri	https://hdl.handle.net/10023/12373
dc.description	The TWENDE consortium (https://infection.st-andrews.ac.uk/twende-overview/) is funded by the European and Developing Countries Clinical Trials Partnership (EDCTP).	en
dc.format.extent	443729
dc.language.iso	eng
dc.relation.ispartof	Journal of Infectious Diseases & Travel Medicine	en
dc.title	Fighting antimicrobial resistance : who should lead the agenda?	en
dc.type	Journal item	en
dc.contributor.institution	University of St Andrews. School of Medicine	en
dc.contributor.institution	University of St Andrews. Gillespie Group	en
dc.contributor.institution	University of St Andrews. Infection and Global Health Division	en
dc.description.status	Peer reviewed	en